A new metabolic mechanism describes how tumors disable “gatekeeper” cells to prevent immune response to cancer.

St. Jude Children's Research Hospital scientists have discovered how tumors disable immune "gatekeeper" cells that alert the ...

St. Jude Children's Research Hospital scientists have discovered how tumors disable immune "gatekeeper" cells that alert the rest of the immune system to the presence of cancer - and how restoring ...

April 02, 2026) St. Jude Children's Research Hospital scientists have discovered how tumors disable immune "gatekeeper" cells that ...

Booking Health, a global medical travel provider, announced today the release of its 2026 report on advanced head and neck ...

The Pan Am Cancer Treatment Centers was started in 2009 to provide patients cutting edge personalized immunotherapies including dendritic cells, allogeneic NK cells, and neoantigen peptide vaccination ...

Published on March 23, 2026, in Volume 2, article number 18 of the journal Immunity & Inflammation , the review begins by systematically outlining ...

Prize winner’s research reprograms tumor cells to trigger antitumor immunity   Cancer immunotherapies, such as checkpoint ...

A new experimental vaccine takes aim at one of tuberculosis’s most stubborn defenses: the ability of bacteria to persist ...

The approach fuses two tuberculosis genes with the goal of directing the immune system to fight drug-tolerant bacterial ...

Overcoming efficacy, safety, and manufacturing hurdles through innovative personalized cancer vaccine design ...